SCHEMBL15768409

SCHEMBL15768409

O=[PH](O)C(NC(c1ccccc1)c1ccccc1)c1ccsc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.40
TDO2 P48775 1/20 0.40
SLC6A9 P48067 1/20 0.38
SLC6A5 Q9Y345 1/20 0.38
MAPT P10636 1/20 0.38
HPGDS O60760 5/20 0.35
MTOR P42345 1/20 0.34
RAB9A P51151 1/20 0.34
GRM7 Q14831 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A3 Q01959 1/20 0.34
HPGD P15428 1/20 0.33
CYP3A4 P08684 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
ALOX5 P09917 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
OPRM1 P35372 1/20 0.31
OPRD1 P41143 1/20 0.31
ALDH1A1 P00352 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1764167 0.84 MTOR (0.39) HPGDSMTORRAB9AGRM7HPGD
SCHEMBL4630138 0.75 MAPT (0.45) IDO1TDO2SLC6A9SLC6A5MAPT
SCHEMBL1764214 0.71 CTRB1 (0.48) CYP3A4TSHRSMN1; SMN2ALDH1A1
SCHEMBL8458472 0.70 CYP2D6 (0.47) IDO1TDO2SLC6A9SLC6A5MAPT
SCHEMBL1764563 0.68 TSHR (0.41) MAPTHPGDSMTORRAB9AGRM7
SCHEMBL1764264 0.66 ALOX5 (0.42) IDO1TDO2ALOX5
SCHEMBL477486 0.65 IDO1 (0.52) IDO1TDO2SLC6A2SLC6A3HPGD
SCHEMBL8580097 0.65 TDP1 (0.48) IDO1TDO2SLC6A2SLC6A3HPGD
SCHEMBL27931250 0.65 IDO1 (0.55) IDO1TDO2MAPTMTORRAB9A
SCHEMBL3874438 0.64 EPHX1 (0.41) MTORRAB9AGRM7SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10131681-B2 Aminophosphinic derivatives that can be used in the treatment of pain PHARMALEADS (FR) 2018-11-20 US disclosed
US-20140161839-A1 AMINOPHOSPHINIC DERIVATIVES THAT CAN BE USED IN THE TREATMENT OF PAIN PHARMALEADS (FR) 2014-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10131681-B2 Aminophosphinic derivatives that can be used in the treatment of pain OPRM1, HRH3, HRH4 IDO1 1217/4885TDO2 623/4885SLC6A9 800/4885
US-20140161839-A1 AMINOPHOSPHINIC DERIVATIVES THAT CAN BE USED IN THE TREATMENT OF PAIN OPRM1, HRH3, HRH4 IDO1 1217/4885TDO2 623/4885SLC6A9 800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.